TGFBR2 and breast cancer: Interestingly, abrogation of aTGFβ signaling via dominant-negative interference with TβRII or kinase inhibition of the type I receptor (TβRI) ALK5 in a BC cell line decreased the levels of activated ERK but increased those of p21WAF1 and induction of apoptosis [20].